7-(Chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine

Catalog No. :
ACRIKN776
CAS No. :
439096-11-4
Molecular Formula :
C20H9Cl3F5N3
Molecular Weight :
492.66

IUPAC Name:7-(chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-(4-(trifluoromethyl)phenyl)pyrazolo[1,5-a]pyrimidine

7-(Chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(Chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine
IUPAC Name7-(chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-(4-(trifluoromethyl)phenyl)pyrazolo[1,5-a]pyrimidine
Molecular FormulaC20H9Cl3F5N3
Molecular Weight492.66
SMILESFC(C1=CC=C(C2=NC3=CC(C4=CC=C(Cl)C(Cl)=C4)=NN3C(C(F)(Cl)F)=C2)C=C1)(F)F
InChI KeyWKVFFFHXUBMGFU-UHFFFAOYSA-N
Synonym7-[chloro(difluoro)methyl]-2-(3,4-dichlorophenyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine;Pyrazolo[1,5-a]pyrimidine, 7-(chlorodifluoromethyl)-2-(3,4-dichlorophenyl)-5-[4-(trifluoromethyl)phenyl]-
CAS No.439096-11-4

Synthetic Route by SureRoute

1. ACRIKN776 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGBLC269 route compound structure diagram
    ACGBLC269128796-39-4 In Stock
  4. Then
  5. ACRIKN776 route product structure diagram
    ACRIKN776439096-11-4
Inquiry

2. ACRIKN776 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJOML365 route compound structure diagram
    ACJOML365151169-75-4 In Stock
  4. Then
  5. ACRIKN776 route product structure diagram
    ACRIKN776439096-11-4
Inquiry

Comments (0)